Relatório de Análise do Tamanho, Participação e Tendências do Mercado Global de Plastômeros Médicos – Visão Geral do Setor e Previsão até 2033

Tamanho do mercado de plastômeros médicos

• O mercado global de plastômeros médicos foi avaliado em US$ 1.130,71 bilhões em 2025  e deverá atingir  US$ 1.727,40 bilhões até 2033 , com uma taxa de crescimento anual composta (CAGR) de 5,44% durante o período de previsão.
• O crescimento do mercado é impulsionado principalmente pela crescente adoção de materiais médicos avançados e inovações tecnológicas na área da saúde, resultando em melhor desempenho, durabilidade e biocompatibilidade dos dispositivos médicos.
• Além disso, a crescente demanda por componentes médicos leves, flexíveis e personalizáveis ​​está impulsionando a adoção de soluções de plastômeros médicos na fabricação de dispositivos médicos, sistemas de administração de medicamentos e produtos médicos descartáveis. Esses fatores convergentes estão impulsionando significativamente o crescimento do mercado de plastômeros médicos.

Análise do Mercado de Plastômeros Médicos

• Os plastômeros médicos, que oferecem soluções poliméricas flexíveis, biocompatíveis e duráveis, são componentes cada vez mais vitais em dispositivos médicos, sistemas de administração de medicamentos e produtos descartáveis ​​para a área da saúde, devido à sua versatilidade, segurança e desempenho em aplicações clínicas.
• A crescente demanda por plastômeros médicos é impulsionada principalmente pela adoção cada vez maior em aplicações avançadas de saúde, pelo aumento da pesquisa e desenvolvimento em soluções médicas à base de polímeros e pela necessidade crescente de materiais de alto desempenho e custo-benefício em hospitais, clínicas e fabricantes de dispositivos médicos.
• A América do Norte dominou o mercado de plastômeros médicos com a maior participação na receita, de 37,8% em 2025, impulsionada por uma infraestrutura de saúde bem estabelecida, fortes capacidades de P&D, alta adoção de tecnologias médicas avançadas e a presença de importantes players do setor em soluções médicas à base de polímeros.
•  A região Ásia-Pacífico deverá ser a de crescimento mais rápido no mercado de plastômeros para uso médico durante o período de previsão, com uma taxa de crescimento anual composta (CAGR) projetada de 8,6%, impulsionada pelo aumento dos gastos com saúde, rápida urbanização, crescente número de fabricantes de dispositivos médicos e demanda cada vez maior por materiais poliméricos de baixo custo e alto desempenho.
• O segmento de filmes detinha a maior participação na receita de mercado, com aproximadamente 41,2% em 2025, devido ao seu amplo uso em embalagens médicas, bolsas estéreis e camadas de barreira para produtos farmacêuticos.

Escopo do relatório e segmentação do mercado de plastômeros médicos 

Tendências do mercado de plastômeros médicos

Adoção crescente em aplicações médicas minimamente invasivas e avançadas

• O mercado global de plastômeros para uso médico está testemunhando uma tendência significativa de aumento de aplicação em procedimentos minimamente invasivos, dispositivos médicos avançados e soluções centradas no paciente.
• Esses materiais são altamente valorizados por sua flexibilidade, durabilidade, resistência química e biocompatibilidade, tornando-os ideais para uso em cateteres, tubos, dispositivos implantáveis ​​e instrumentos cirúrgicos.
  • Por exemplo, a Medtronic integrou elastômeros termoplásticos avançados em seus cateteres cardíacos, aumentando a flexibilidade e minimizando o desconforto do paciente. A B. Braun adotou tubos à base de plastômero para sistemas de infusão, a fim de melhorar a resistência a dobras e garantir a administração de fluidos estéreis. Da mesma forma, a Boston Scientific utiliza plastômeros especializados em dispositivos endoscópicos para proporcionar manobrabilidade precisa durante procedimentos delicados.
• A tendência para dispositivos descartáveis ​​de uso único está impulsionando a adoção, visto que os plastômeros médicos são mais fáceis de esterilizar e mantêm um desempenho consistente em comparação com os materiais convencionais.
• A tendência em direção a dispositivos médicos biodegradáveis ​​e ecológicos também está crescendo, com empresas explorando plastômeros recicláveis ​​e compostáveis ​​de grau médico para atender às preocupações com a sustentabilidade.
• Os plastômeros médicos estão sendo cada vez mais utilizados em dispositivos vestíveis para a área da saúde, como tubos flexíveis para bombas de insulina e componentes flexíveis em sistemas portáteis de administração de oxigênio, oferecendo conforto ao paciente e confiabilidade ao dispositivo.
• O crescente investimento em P&D para desenvolver plastômeros de alto desempenho capazes de suportar processos extremos de esterilização (autoclavagem, irradiação gama) está fortalecendo ainda mais sua adoção em unidades de terapia intensiva.

Dinâmica do mercado de plastômeros médicos

Motorista

Expansão da infraestrutura de saúde e aumento da demanda por dispositivos médicos

• A crescente prevalência de doenças crônicas, a expansão dos procedimentos cirúrgicos e a maior conscientização sobre soluções avançadas de saúde estão impulsionando a adoção de plastômeros médicos em todo o mundo. Hospitais, centros de atendimento ambulatorial e clínicas especializadas estão integrando dispositivos à base de plastômeros para melhorar a segurança do paciente, a precisão e a facilidade de uso.
  • Por exemplo, em 2025, o Apollo Hospitals, na Índia, aumentou o uso de cateteres e tubos à base de plastômero em unidades de terapia intensiva cardíaca e neonatal, melhorando os resultados para os pacientes e a confiabilidade dos dispositivos. A Philips Healthcare, na Europa, integrou componentes médicos de plastômero em sistemas cirúrgicos minimamente invasivos, aumentando a flexibilidade dos dispositivos e reduzindo as complicações dos procedimentos.
• A tendência de cirurgias ambulatoriais e intervenções minimamente invasivas está acelerando ainda mais a demanda, visto que os dispositivos à base de plastômero são leves, flexíveis e compatíveis com instrumentos cirúrgicos avançados.
• Iniciativas governamentais de saúde em mercados emergentes, como a Missão Nacional de Saúde da Índia e o plano China Saudável 2030, estão aumentando os investimentos em infraestrutura médica moderna, impulsionando indiretamente a demanda por plastômeros para dispositivos e materiais de consumo essenciais.
• A colaboração entre fornecedores de materiais e fabricantes de equipamentos originais (OEMs) está impulsionando a inovação no design de dispositivos. Empresas como a Teknor Apex e a Elastomer Solutions oferecem formulações personalizadas para aprimorar a resistência mecânica, a resistência química e a tolerância à esterilização.
• O crescimento da classe média na região Ásia-Pacífico e na América Latina, juntamente com a maior cobertura de planos de saúde para procedimentos avançados, está impulsionando a adoção de dispositivos médicos de alto desempenho à base de plastômeros.

Restrição/Desafio

Custos elevados, dependências da cadeia de suprimentos e barreiras regulatórias.

• Os plastômeros avançados de grau médico são geralmente mais caros do que os polímeros tradicionais, o que pode representar um desafio para os prestadores de serviços de saúde com orçamentos limitados e para os fabricantes de equipamentos originais (OEMs) de menor porte, especialmente em regiões em desenvolvimento.
  • Por exemplo, os implantes ortopédicos à base de plastômero da Stryker têm um preço elevado, enquanto fabricantes menores de tecnologia médica no Sudeste Asiático têm dificuldades para obter elastômeros aprovados pelo FDA ou com marcação CE em quantidades suficientes para produção em larga escala.
• Normas regulatórias rigorosas para polímeros de grau médico, incluindo testes de biocompatibilidade ISO 10993, aprovações da FDA e certificações CE, podem aumentar significativamente os prazos e custos de desenvolvimento.
• Supply chain dependencies on specialty chemical suppliers can create bottlenecks, particularly for high-performance thermoplastic elastomers with precise chemical and mechanical properties. Delays in sourcing these raw materials may disrupt production cycles and increase costs
• In addition, variations in sterilization requirements across different medical applications (gamma irradiation, autoclaving, ethylene oxide sterilization) require plastomers with highly specific properties, adding complexity to material selection and device design
• Price sensitivity, coupled with lack of awareness among small-scale device manufacturers about the advantages of plastomers over conventional materials, can slow adoption in emerging markets
• Overcoming these challenges involves investment in advanced supply chain management, R&D for cost-effective formulations, regulatory compliance expertise, and educational initiatives to highlight the long-term benefits of medical plastomer adoption in improving patient outcomes and device reliability

Medical Plastomer Market Scope

The market is segmented on the basis of product, type, and processing.

• By Product

On the basis of product, the Medical Plastomer market is segmented into Ethylene Propylene, Ethylene Butene, Ethylene Hexene, and Ethylene Octene. The Ethylene Propylene segment dominated the largest market revenue share of approximately 38.5% in 2025, owing to its superior flexibility, chemical resistance, and biocompatibility, which make it ideal for medical tubing, seals, and gaskets. Its compatibility with sterilization processes such as gamma irradiation and autoclaving ensures widespread adoption in hospitals, clinics, and pharmaceutical packaging. The segment benefits from established supply chains and high availability of raw materials. Medical device manufacturers prefer Ethylene Propylene for its stable physical and mechanical properties, ensuring consistent product performance. Rising demand for disposable medical devices, such as catheters and IV sets, drives consumption. Regulatory approvals in multiple regions support market dominance. High processability and recyclability further strengthen the segment’s position. Global awareness about patient safety and hygiene standards fuels preference. Long-term contracts between OEMs and suppliers stabilize revenues. Integration into complex medical device assemblies reinforces market share. Its broad application across tubing, seals, and flexible packaging continues to support sustained growth.

The Ethylene Hexene segment is expected to witness the fastest CAGR of around 22.8% from 2026 to 2033, driven by increasing demand for high-performance plastomers with superior elasticity and tensile strength. Rising applications in flexible medical packaging, protective films, and advanced tubing boost adoption. Ethylene Hexene’s compatibility with co-extrusion and multi-layer structures allows enhanced barrier properties. Expanding pharmaceutical packaging and single-use medical device markets further accelerate growth. Its use in high-volume production lines reduces operational costs for manufacturers. Innovations in material blends enhance performance for specialized applications. Growing adoption in minimally invasive devices supports expansion. Regulatory compliance for safe use in healthcare settings ensures trust. Development of new extrusion and molding techniques contributes to efficiency. Emerging markets in Asia-Pacific drive additional demand. Continuous R&D on high-performance resins sustains adoption. Rising awareness of plastomer advantages over conventional polymers fuels growth momentum.

• By Type

On the basis of type, the Medical Plastomer market is segmented into Wires and Cables, Film, and Packaging. The Film segment held the largest market revenue share of approximately 41.2% in 2025, owing to its extensive use in medical packaging, sterile pouches, and barrier layers for pharmaceuticals. Films provide excellent flexibility, puncture resistance, and oxygen/moisture barrier properties critical for medical product integrity. High compatibility with sterilization processes, such as ethylene oxide and gamma radiation, further strengthens adoption. Growing demand from hospitals and pharmaceutical industries for safe, single-use packaging drives market dominance. Multi-layer film structures enable advanced performance for medical devices. Regulatory certifications for safe medical contact support industry preference. Film’s adaptability to flexible and rigid applications makes it a key choice. Long shelf-life and product protection enhance commercial appeal. Automated production systems ensure consistent quality and supply. Film manufacturing supports large-scale production needs. Rising focus on patient safety drives higher utilization. Integration into medical device assemblies maintains sustained dominance.

The Packaging segment is expected to witness the fastest CAGR of around 23.5% from 2026 to 2033, fueled by the growing trend of pre-filled syringes, IV sets, and single-use medical kits. Increasing global demand for sterile, tamper-evident, and leak-proof packaging accelerates adoption. Medical Plastomers in packaging offer excellent chemical resistance and high transparency. Rapid growth in pharmaceutical logistics and home healthcare solutions supports market expansion. Enhanced barrier films improve drug stability and shelf-life. Flexible designs enable cost-efficient production and transport. Regulatory emphasis on patient safety encourages outsourcing to specialized packaging manufacturers. Emerging markets with expanding healthcare infrastructure drive additional growth. Increasing focus on eco-friendly and recyclable packaging boosts adoption. New extrusion and lamination techniques enhance performance. Rising outsourcing of packaging operations to specialized vendors sustains momentum. Growth of e-pharmacies and home delivery of healthcare products strengthens segment CAGR.

• By Processing

On the basis of processing, the Medical Plastomer market is segmented into Blow Film Extrusion, Cast Film Extrusion, Extrusion Coating, Injection Molding, and Others. The Blow Film Extrusion segment dominated the largest market revenue share of approximately 36.8% in 2025, driven by its cost-effectiveness and ability to produce multi-layer medical films for packaging and disposable devices. Blow film extrusion allows consistent thickness control, superior barrier properties, and flexibility, critical for medical applications. Hospitals and pharmaceutical companies rely on this method for high-volume production. The technology supports customization for patient-centric packaging solutions. Integration with automated sterilization and sealing systems enhances efficiency. Long-standing adoption and established expertise strengthen market position. Multi-layer co-extrusions further improve functionality. Compliance with ISO and FDA standards supports segment leadership. Rapid production cycles reduce manufacturing costs. Enhanced mechanical properties maintain reliability in transport and storage. Availability of skilled workforce ensures operational efficiency. Innovation in extrusion dies improves throughput and quality control. High demand in single-use disposables sustains dominance.

The Injection Molding segment is anticipated to witness the fastest CAGR of around 25.2% from 2026 to 2033, driven by the growing demand for complex, high-precision medical components such as syringes, valves, and device housings. The ability to produce intricate geometries with tight tolerances makes it ideal for medical devices. Increasing adoption of automation and robotics in molding operations enhances efficiency. Rising use in implantable devices and surgical instruments fuels growth. Regulatory compliance for biocompatibility supports adoption. Emerging markets are investing in advanced molding facilities. Technological innovation in mold design improves cycle times. Demand for personalized medical devices accelerates production needs. High repeatability and material efficiency reduce costs. Expansion in the diagnostic and drug delivery markets drives volume. OEMs prefer outsourcing injection molding for scalability. Integration with multi-material molding boosts segment CAGR. Continuous focus on precision and quality assurance ensures sustainable growth.

Medical Plastomer Market Regional Analysis

• North America dominated the medical plastomer market with the largest revenue share of 37.8% in 2025, supported by well-established healthcare infrastructure, strong R&D capabilities, and the presence of key industry players offering polymer-based medical solutions. The U.S., in particular, accounts for the majority of the regional revenue due to high adoption of advanced medical technologies and increased demand for disposable and high-performance medical devices. Hospitals and clinics in the region are increasingly using Medical Plastomer components for tubing, seals, films, and packaging materials due to their superior biocompatibility and durability
• High awareness about patient safety, stringent regulatory frameworks, and the availability of skilled workforce further enhance market penetration. The presence of major polymer manufacturers and consistent supply chains ensures the availability of quality materials. Rising investments in innovative healthcare solutions, coupled with a focus on cost-effective manufacturing, strengthen the market. Multi-layer film and injection-molded components see strong adoption in diagnostics and surgical applications
• Long-term collaborations between OEMs and suppliers stabilize revenue streams. The demand for high-performance materials in both implantable and non-implantable devices continues to drive growth. North America remains a hub for product innovation and commercialized Medical Plastomer applications

U.S. Medical Plastomer Market Insight

The U.S. medical plastomer market captured the largest revenue share within North America in 2025, making it the leading contributor to the regional market. Growth is driven by a highly developed healthcare infrastructure, strong R&D capabilities, and early adoption of advanced polymer-based medical technologies. Hospitals, specialty clinics, and outpatient centers increasingly rely on Medical Plastomer components for tubing, films, packaging, and injection-molded devices due to their superior biocompatibility, durability, and chemical resistance. The demand for disposable devices, minimally invasive surgical tools, and high-performance medical packaging fuels market expansion. High consumer awareness, stringent regulatory standards, and focus on patient safety further strengthen market penetration. Collaborations between OEMs and local polymer suppliers ensure consistent material supply. The U.S. market also benefits from innovation in multi-layer film, co-extrusion, and extrusion coating technologies. The rise of home healthcare, telemedicine, and outpatient treatments supports ongoing material demand. In addition, strong investments in healthcare automation and smart medical devices contribute to the market’s revenue growth. Cost-efficiency, high-quality standards, and a robust domestic supply chain further solidify the U.S.’s leading position in Medical Plastomer adoption.

Europe Medical Plastomer Market Insight

The Europe medical plastomer market held a significant share in 2025 and is projected to expand at a robust CAGR over the forecast period, driven by a growing emphasis on healthcare quality, regulatory compliance, and technological advancements in medical devices. Germany, France, and the U.K. are key contributors, with demand stemming from advanced hospitals, specialty clinics, and pharmaceutical packaging applications. The adoption of polymer-based solutions in catheters, tubing, films, and packaging ensures product safety and flexibility. European manufacturers are increasingly integrating sustainable, eco-conscious materials in line with regulatory guidelines. The growing prevalence of chronic diseases and expansion of minimally invasive surgeries support material adoption. Multi-layer films for sterile packaging and injection-molded components for surgical devices are particularly in demand. Hospitals and medical device OEMs are emphasizing patient safety, driving standardized use of Medical Plastomer components. Advanced R&D and collaborations with global polymer producers support product innovation. Consumer awareness and the adoption of new medical technologies further stimulate growth. The region’s strong healthcare spending and focus on precision medicine contribute to ongoing market expansion.

U.K. Medical Plastomer Market Insight

The U.K. medical plastomer market is anticipated to grow at a noteworthy CAGR, supported by the country’s adoption of advanced medical devices and polymer-based components for both hospitals and specialty clinics. Rising investments in healthcare infrastructure, coupled with increased focus on disposable and sterile medical products, drive demand. The U.K. market emphasizes biocompatibility, safety, and regulatory compliance, encouraging widespread use in diagnostics, surgical devices, and medical packaging. Growing outpatient and home healthcare services expand the need for cost-effective and high-performance plastomer components. The presence of leading polymer and medical device manufacturers ensures a robust supply chain. Focus on sustainable and recyclable materials aligns with regulatory and consumer expectations. Increased adoption of injection-molded devices, multi-layer films, and tubing solutions fuels demand. The market also benefits from a growing number of ambulatory surgical centers and clinics requiring high-quality materials. Collaboration with global suppliers enhances product innovation. The rise of e-health and home monitoring devices contributes to increasing plastomer usage. Continued urbanization and technological adoption maintain steady market growth.

Germany Medical Plastomer Market Insight

The Germany medical plastomer market is expected to expand at a considerable CAGR, driven by technological advancements, strong healthcare infrastructure, and a focus on eco-friendly and high-performance polymeric materials. Germany’s hospitals and specialty clinics prioritize safety, biocompatibility, and material reliability, promoting widespread adoption of Medical Plastomer components. Injection-molded devices, tubing, films, and packaging are widely used across diagnostics, surgical, and drug delivery applications. The region benefits from established R&D centers collaborating with polymer producers to innovate high-performance materials. Regulatory compliance with EU and local standards ensures safety and reliability. Adoption of minimally invasive surgeries, home care solutions, and outpatient services increases material demand. Multi-layer films, co-extrusions, and extrusion coating technologies are becoming standard for medical packaging. Industrial partnerships support large-scale production. Continuous innovation and material upgrades drive consistent revenue. Awareness about hygiene, patient safety, and sustainable solutions further reinforces market adoption. Germany continues to be a hub for high-quality Medical Plastomer applications in Europe.

Asia-Pacific Medical Plastomer Market Insight

The Asia-Pacific medical plastomer market is expected to be the fastest-growing region with a projected CAGR of 8.6% during 2026–2033. Growth is fueled by rising healthcare expenditure, rapid urbanization, and the increasing number of medical device manufacturers across China, Japan, and India. Expanding hospitals, specialty clinics, and diagnostic centers are driving demand for cost-effective, high-performance polymeric materials. Medical Plastomers are increasingly used in tubing, seals, films, packaging, and disposable devices, supported by local manufacturing hubs that enhance affordability and accessibility. Government initiatives promoting healthcare infrastructure and digitalization contribute to market growth. Rapid adoption of minimally invasive devices, home care solutions, and disposable medical products accelerates demand. Expansion of domestic polymer producers ensures a steady supply. Investment in R&D supports product customization and innovation for local needs. Regulatory improvements and safety awareness encourage adoption of high-quality materials. Multi-layer films, extrusion coating, and injection-molded components are increasingly utilized. The Asia-Pacific market benefits from cost advantages, large patient populations, and growing medical device export opportunities.

Japan Medical Plastomer Market Insight

The Japan medical plastomer market is gaining momentum due to rapid urbanization, high-tech healthcare adoption, and demand for innovative medical solutions. Hospitals and specialty clinics emphasize safety, reliability, and biocompatibility, boosting demand for tubing, films, packaging, and injection-molded devices. Aging population and home care solutions increase the need for disposable and easy-to-use medical products. Integration of Medical Plastomer components in diagnostics, surgical, and drug delivery devices continues to rise. Government incentives and technological innovation support material adoption. Regulatory compliance ensures high-quality, safe usage. Collaboration with local polymer manufacturers enhances efficiency and product development. Continuous innovation in blow film and cast film extrusion technologies improves production. Adoption of eco-friendly and recyclable solutions strengthens market appeal. Expansion of healthcare networks and outpatient services supports growth. Rising medical device exports further contribute to demand. Japan maintains strong adoption of advanced polymer-based solutions in the healthcare sector.

China Medical Plastomer Market Insight

O mercado chinês de plastômeros para uso médico representou a maior fatia de receita na região Ásia-Pacífico em 2025, impulsionado pela rápida urbanização, expansão da infraestrutura de saúde e crescimento da fabricação de dispositivos médicos. O país é um importante polo para soluções médicas à base de polímeros, incluindo tubos, filmes, embalagens e dispositivos moldados por injeção. A crescente demanda interna por materiais de baixo custo e alto desempenho impulsiona a adoção. Iniciativas governamentais para aprimoramento da saúde e infraestrutura hospitalar inteligente alimentam o crescimento. A forte presença de fabricantes locais de polímeros garante a disponibilidade constante de materiais. O mercado se beneficia de uma grande população de pacientes e do aumento dos serviços ambulatoriais e de assistência domiciliar. A rápida adoção de cirurgias minimamente invasivas e dispositivos descartáveis ​​aumenta a demanda. Filmes multicamadas e tecnologias de coextrusão melhoram o desempenho das embalagens. Melhorias regulatórias aumentam a confiança na segurança dos produtos. A expansão das exportações nacionais e internacionais de dispositivos médicos sustenta o crescimento da produção. Inovação contínua e investimentos em P&D mantêm o ritmo do mercado. Espera-se que a China mantenha a liderança na região Ásia-Pacífico devido à escala, à eficiência de custos e ao avanço tecnológico.

Participação de mercado de plastômeros médicos

A indústria de plastômeros médicos é liderada principalmente por empresas consolidadas, incluindo:

• ExxonMobil Chemical (EUA)
• INEOS (Reino Unido)
• LyondellBasell Industries (Países Baixos)
• Empresa Dow Chemical (EUA)
• SABIC (Arábia Saudita)
• Borealis AG (Áustria)
• Chevron Phillips Chemical (EUA)
• WR Grace & Co. (EUA)
• Repsol SA (Espanha)
• Formosa Plastics Corp. (Taiwan)
• Japan Polychem Corp. (Japão)
• LCY Chemical Corp. (Taiwan)
• Arkema SA (França)
• Materiais de Engenharia DSM (Países Baixos)
• Mitsui Chemicals (Japão)

Últimos desenvolvimentos no mercado global de plastômeros médicos

• Em abril de 2023, a BASF SE anunciou a expansão de suas formulações de poliuretano termoplástico (TPU) e plastômero de grau médico, projetadas para uso em dispositivos e componentes médicos flexíveis, com o objetivo de melhorar a biocompatibilidade, o desempenho de esterilização e as propriedades mecânicas em aplicações críticas na área da saúde.
• Em janeiro de 2024, a BASF inaugurou sua maior linha de produção de poliuretano termoplástico no complexo industrial de Zhanjiang Verbund, na China, para atender à crescente demanda por elastômeros e materiais relacionados a plastômeros utilizados em tubos, cateteres e dispositivos vestíveis para uso médico, possibilitando maior capacidade de produção para o setor de saúde.
• Em julho de 2025, a DuPont e a Medline Industries anunciaram uma parceria estratégica para o codesenvolvimento e fornecimento de formulações avançadas de elastômeros e plastômeros para dispositivos médicos descartáveis, padronizando materiais biocompatíveis de alto desempenho em diversas famílias de dispositivos e ampliando a disponibilidade global de materiais.
• Em março de 2025, a Zeon Corporation lançou um novo elastômero de silicone de grau médico (uma classe de material relacionado ao plastômero) especificamente desenvolvido para aplicações em cateteres, com biocompatibilidade e estabilidade de esterilização aprimoradas, ampliando as opções de alto desempenho para dispositivos de terapia intensiva.

SKU-65675